Women's Kidney Stone Rates Have Doubled. Your Platform Reaches Them First.
Female kidney stone prevalence jumped from 4% in the 1990s to nearly 10% today. Bellabeat tracks cycles, stress, and activity for millions of women — but not the dietary factor driving the fastest-growing stone demographic. OxalateGuard closes that gap.
Partnership Proposal — Not Yet Active
OxalateGuard is not currently partnered with Bellabeat. This page outlines why we believe our products are a natural fit and how a partnership could benefit both Bellabeat users and kidney stone patients. We'd love to make it happen.
Women's Stone Risk Is Rising — and Underserved
The Gender Gap in Kidney Stone Prevention
Kidney stone prevalence in women has risen from 3.8% to 9.4% in two decades (NHANES data). Yet most kidney stone tools and research still default to male patients. Bellabeat is built for women — and women need this.
The Spring Tracks Water. Not What's in the Food.
The PUSH trial (2024) proved hydration alone doesn't prevent kidney stones. Bellabeat Spring tracks water intake beautifully, but the dietary side — oxalate from spinach smoothies, almond milk, turmeric lattes — is invisible.
Pregnancy Is a High-Risk Window Nobody Flags
Kidney stones during pregnancy affect 1 in 200–1,500 pregnancies and are the leading non-obstetric cause of hospitalization. Bellabeat already tracks pregnancy wellness. Adding oxalate awareness during this vulnerable window is a natural fit.
How OxalateGuard Complements Bellabeat
First Women's Health Platform with Stone Prevention
No women's health app addresses kidney stones. By integrating OxalateGuard data, Bellabeat becomes the first to connect menstrual health, hydration, stress, and dietary oxalate in one ecosystem.
Access 33 Million Kidney Stone Patients
One in 11 Americans has had a kidney stone. Women are the fastest-growing segment. OxalateGuard's 2,500+ food database and barcode scanner give Bellabeat users a reason to engage daily — not just during their cycle.
Ivy Wellness Score + Dietary Correlation
Ivy tracks heart rate, respiratory rate, activity, and produces a daily wellness score. Correlating that score with dietary oxalate intake creates a feedback loop no competitor offers: feel worse on high-oxalate days? Now you can see why.
Gender-Specific Content That Converts
OxalateGuard's data is gender-neutral, but the framing matters. Women-specific content — pregnancy risk, hormonal factors, popular high-oxalate 'wellness' foods like matcha and acai — drives engagement in Bellabeat's core demographic.
How a Partnership Could Work
Spring Hydration Sync
Connect Bellabeat Spring water intake data with OxalateGuard's dietary tracking. Users see hydration and oxalate load side by side — the complete kidney health picture.
Ivy Wellness Correlation
Surface dietary patterns alongside Ivy's wellness score, heart rate, and activity data. High-oxalate days correlated with lower wellness scores create actionable insights.
Women's Health Co-Marketing
Joint campaigns targeting the underserved female kidney stone demographic. Bellabeat's 'women's health' authority + OxalateGuard's clinical data = a category-defining partnership.
Pregnancy Wellness Module
Add oxalate awareness to Bellabeat's pregnancy tracking. Flag high-risk foods, suggest safe swaps, and reduce the leading non-obstetric cause of pregnancy hospitalization.
Other Device Partnerships
Prefer to talk?
(803) 303-0060Schedule a Partnership Call
Tell us about your product and we'll follow up within one business day.
Frequently Asked Questions
Is OxalateGuard affiliated with Bellabeat?
Are women really at higher risk for kidney stones now?
How does pregnancy increase kidney stone risk?
Can Bellabeat users already use OxalateGuard?
Do popular women's wellness foods contain oxalate?
OxalateGuard is not affiliated with Bellabeat or Bellabeat, Inc.. Bellabeat is a trademark of Bellabeat, Inc.. This page describes a potential partnership opportunity and does not imply any existing business relationship.